Faron Pharmaceuticals Oy (DI) (FARN) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Mar 2025 12:05 PM
RNS
FDA Grants Orphan Drug Designation
28 Feb 2025 12:00 PM
RNS
Notice of Annual General Meeting
27 Feb 2025 07:30 AM
RNS
Positive EMA Opinion on Orphan Drug Designation
27 Feb 2025 07:15 AM
RNS
Annual Report 2024 published
27 Feb 2025 07:00 AM
RNS
Financial Statement 1 January to 31 December 2024
19 Feb 2025 10:00 AM
RNS
Notice of Financial Statement and Annual Report
14 Feb 2025 12:00 PM
RNS
Holding(s) in Company
11 Feb 2025 07:30 AM
RNS
Change of Broker
06 Feb 2025 03:00 PM
RNS
Holding(s) in Company
06 Feb 2025 07:00 AM
RNS
Results of Oversubscribed Placing
05 Feb 2025 04:30 PM
RNS
Proposed Issue and Placing
31 Jan 2025 07:00 AM
RNS
Final Patient Identified for BEXMAB Phase II Study
13 Dec 2024 07:00 AM
RNS
Faron’s Financial Calendar for 2025
10 Dec 2024 07:00 AM
RNS
Faron presents BEXMAB data at ASH Annual Meeting
02 Dec 2024 08:00 AM
RNS
Interactions with UK Regulatory Authorities
27 Nov 2024 07:00 AM
RNS
Positive Phase 2 Interim Results from BEXMAB Trial
11 Nov 2024 07:00 AM
RNS
Targeting Soluble Clever-1 for Autoimmune Diseases
05 Nov 2024 07:00 AM
RNS
Shareholders’ Nomination Board
22 Oct 2024 07:00 AM
RNS
Faron’s Capital Markets Day 2024
07 Oct 2024 07:00 AM
RNS
Faron announces Capital Markets Day
30 Aug 2024 07:00 AM
RNS
Grant of options
27 Aug 2024 07:00 AM
RNS
Faron 2024 Half-Year Financial Results
27 Aug 2024 07:00 AM
RNS
FDA Grants Fast Track Designation for Bexmarilimab
20 Aug 2024 07:00 AM
RNS
Notice of Half-Year Financial Results
13 Aug 2024 07:00 AM
RNS
Traumakine Research Collaboration and DoD Grant
08 Aug 2024 07:00 AM
RNS
Appointment of Chief Financial Officer
07 Aug 2024 10:00 AM
RNS
Grant of options
06 Aug 2024 08:30 AM
RNS
Faron Appoints Dr. Petri Bono as new CMO
11 Jul 2024 07:00 AM
RNS
Faron Announces Positive FDA Feedback
25 Jun 2024 02:00 PM
RNS
Update on settlement
25 Jun 2024 10:30 AM
RNS
Holding(s) in Company - Replacement
24 Jun 2024 12:45 PM
RNS
Holding(s) in Company
24 Jun 2024 12:45 PM
RNS
Holding(s) in Company
24 Jun 2024 12:45 PM
RNS
Holding(s) in Company
24 Jun 2024 12:45 PM
RNS
Holding(s) in Company
20 Jun 2024 01:00 PM
RNS
New shares registered with Finnish Trade Register
20 Jun 2024 07:00 AM
RNS
Fully subscribed EUR 30.7 million share offering
05 Jun 2024 08:00 AM
RNS
Proposed REX Retail Offer
04 Jun 2024 07:00 AM
RNS
Faron commences a share offering
20 May 2024 07:00 AM
RNS
Initial positive data from Phase 2 of BEXMAB
17 May 2024 04:00 PM
RNS
Issuance of warrants
16 May 2024 07:05 AM
RNS
Founders named European Inventor Award finalists
13 May 2024 07:00 AM
RNS
Replacement – Board Change
30 Apr 2024 02:00 PM
RNS
Update on financial status
30 Apr 2024 01:00 PM
RNS
Board Change
16 Apr 2024 07:00 AM
RNS
Faron confirms plans under new leadership
15 Apr 2024 07:00 AM
RNS
Appointment of Chief Financial Officer
08 Apr 2024 07:10 AM
RNS
Approval of Warrant Terms and Conditions
08 Apr 2024 07:05 AM
RNS
Decisions of the Board of Directors
08 Apr 2024 07:00 AM
RNS
Appointment of Chief Executive Officer
UK 100